Abstract

Recent evidence has suggested that dietary polyunsaturated fatty acids (PUFAs) modulate inflammation; however, few studies have focused on the pathobiology of PUFA using isocaloric and isolipidic diets and it is unclear if the associated pathologies are due to dietary PUFA composition, lipid metabolism or obesity, as most studies compare diets fed ad libitum. Our studies used isocaloric and isolipidic liquid diets (35% of calories from fat), with differing compositions of omega (ω)-6 or long chain (Lc) ω-3 PUFA that were pair-fed and assessed hepatic pathology, inflammation and lipid metabolism. Consistent with an isocaloric, pair-fed model we observed no significant difference in diet consumption between the groups. In contrast, the body and liver weight, total lipid level and abdominal fat deposits were significantly higher in mice fed an ω-6 diet. An analysis of the fatty acid profile in plasma and liver showed that mice on the ω-6 diet had significantly more arachidonic acid (AA) in the plasma and liver, whereas, in these mice ω-3 fatty acids such as eicosapentaenoic acid (EPA) were not detected and docosahexaenoic acid (DHA) was significantly lower. Histopathologic analyses documented that mice on the ω-6 diet had a significant increase in macrovesicular steatosis, extramedullary myelopoiesis (EMM), apoptotic hepatocytes and decreased glycogen storage in lobular hepatocytes, and hepatocyte proliferation relative to mice fed the Lc ω-3 diet. Together, these results support PUFA dietary regulation of hepatic pathology and inflammation with implications for enteral feeding regulation of steatosis and other hepatic lesions.

Original languageEnglish (US)
Pages (from-to)92-102
Number of pages11
JournalJournal of Nutritional Biochemistry
Volume52
DOIs
StatePublished - Feb 2018

Fingerprint

Omega-6 Fatty Acids
Pathology
Nutrition
Unsaturated Fatty Acids
Diet
Liver
Hepatocytes
Inflammation
Lipid Metabolism
Fatty Acids
Fats
Myelopoiesis
Plasmas
Abdominal Fat
Eicosapentaenoic Acid
Docosahexaenoic Acids
Enteral Nutrition
Chemical analysis
Glycogen
Arachidonic Acid

Keywords

  • Diet
  • Fatty liver
  • Fish oil
  • Hepatic steatosis
  • Omega-3
  • PUFA

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Biology
  • Nutrition and Dietetics
  • Clinical Biochemistry

Cite this

Dietary omega-3 and omega-6 polyunsaturated fatty acids modulate hepatic pathology. / Khadge, Saraswoti; Sharp, John G; Thiele, Geoffrey Milton; McGuire, Timothy R; Klassen, Lynell Warren; Duryee, Michael J.; Britton, Holly C.; Dafferner, Alicia J.; Beck, Jordan; Black, Paul N; DiRusso, Concetta C; Talmadge, James E.

In: Journal of Nutritional Biochemistry, Vol. 52, 02.2018, p. 92-102.

Research output: Contribution to journalArticle

@article{9939d963404643c28d49acb8d54794ab,
title = "Dietary omega-3 and omega-6 polyunsaturated fatty acids modulate hepatic pathology",
abstract = "Recent evidence has suggested that dietary polyunsaturated fatty acids (PUFAs) modulate inflammation; however, few studies have focused on the pathobiology of PUFA using isocaloric and isolipidic diets and it is unclear if the associated pathologies are due to dietary PUFA composition, lipid metabolism or obesity, as most studies compare diets fed ad libitum. Our studies used isocaloric and isolipidic liquid diets (35{\%} of calories from fat), with differing compositions of omega (ω)-6 or long chain (Lc) ω-3 PUFA that were pair-fed and assessed hepatic pathology, inflammation and lipid metabolism. Consistent with an isocaloric, pair-fed model we observed no significant difference in diet consumption between the groups. In contrast, the body and liver weight, total lipid level and abdominal fat deposits were significantly higher in mice fed an ω-6 diet. An analysis of the fatty acid profile in plasma and liver showed that mice on the ω-6 diet had significantly more arachidonic acid (AA) in the plasma and liver, whereas, in these mice ω-3 fatty acids such as eicosapentaenoic acid (EPA) were not detected and docosahexaenoic acid (DHA) was significantly lower. Histopathologic analyses documented that mice on the ω-6 diet had a significant increase in macrovesicular steatosis, extramedullary myelopoiesis (EMM), apoptotic hepatocytes and decreased glycogen storage in lobular hepatocytes, and hepatocyte proliferation relative to mice fed the Lc ω-3 diet. Together, these results support PUFA dietary regulation of hepatic pathology and inflammation with implications for enteral feeding regulation of steatosis and other hepatic lesions.",
keywords = "Diet, Fatty liver, Fish oil, Hepatic steatosis, Omega-3, PUFA",
author = "Saraswoti Khadge and Sharp, {John G} and Thiele, {Geoffrey Milton} and McGuire, {Timothy R} and Klassen, {Lynell Warren} and Duryee, {Michael J.} and Britton, {Holly C.} and Dafferner, {Alicia J.} and Jordan Beck and Black, {Paul N} and DiRusso, {Concetta C} and Talmadge, {James E}",
year = "2018",
month = "2",
doi = "10.1016/j.jnutbio.2017.09.017",
language = "English (US)",
volume = "52",
pages = "92--102",
journal = "Journal of Nutritional Biochemistry",
issn = "0955-2863",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Dietary omega-3 and omega-6 polyunsaturated fatty acids modulate hepatic pathology

AU - Khadge, Saraswoti

AU - Sharp, John G

AU - Thiele, Geoffrey Milton

AU - McGuire, Timothy R

AU - Klassen, Lynell Warren

AU - Duryee, Michael J.

AU - Britton, Holly C.

AU - Dafferner, Alicia J.

AU - Beck, Jordan

AU - Black, Paul N

AU - DiRusso, Concetta C

AU - Talmadge, James E

PY - 2018/2

Y1 - 2018/2

N2 - Recent evidence has suggested that dietary polyunsaturated fatty acids (PUFAs) modulate inflammation; however, few studies have focused on the pathobiology of PUFA using isocaloric and isolipidic diets and it is unclear if the associated pathologies are due to dietary PUFA composition, lipid metabolism or obesity, as most studies compare diets fed ad libitum. Our studies used isocaloric and isolipidic liquid diets (35% of calories from fat), with differing compositions of omega (ω)-6 or long chain (Lc) ω-3 PUFA that were pair-fed and assessed hepatic pathology, inflammation and lipid metabolism. Consistent with an isocaloric, pair-fed model we observed no significant difference in diet consumption between the groups. In contrast, the body and liver weight, total lipid level and abdominal fat deposits were significantly higher in mice fed an ω-6 diet. An analysis of the fatty acid profile in plasma and liver showed that mice on the ω-6 diet had significantly more arachidonic acid (AA) in the plasma and liver, whereas, in these mice ω-3 fatty acids such as eicosapentaenoic acid (EPA) were not detected and docosahexaenoic acid (DHA) was significantly lower. Histopathologic analyses documented that mice on the ω-6 diet had a significant increase in macrovesicular steatosis, extramedullary myelopoiesis (EMM), apoptotic hepatocytes and decreased glycogen storage in lobular hepatocytes, and hepatocyte proliferation relative to mice fed the Lc ω-3 diet. Together, these results support PUFA dietary regulation of hepatic pathology and inflammation with implications for enteral feeding regulation of steatosis and other hepatic lesions.

AB - Recent evidence has suggested that dietary polyunsaturated fatty acids (PUFAs) modulate inflammation; however, few studies have focused on the pathobiology of PUFA using isocaloric and isolipidic diets and it is unclear if the associated pathologies are due to dietary PUFA composition, lipid metabolism or obesity, as most studies compare diets fed ad libitum. Our studies used isocaloric and isolipidic liquid diets (35% of calories from fat), with differing compositions of omega (ω)-6 or long chain (Lc) ω-3 PUFA that were pair-fed and assessed hepatic pathology, inflammation and lipid metabolism. Consistent with an isocaloric, pair-fed model we observed no significant difference in diet consumption between the groups. In contrast, the body and liver weight, total lipid level and abdominal fat deposits were significantly higher in mice fed an ω-6 diet. An analysis of the fatty acid profile in plasma and liver showed that mice on the ω-6 diet had significantly more arachidonic acid (AA) in the plasma and liver, whereas, in these mice ω-3 fatty acids such as eicosapentaenoic acid (EPA) were not detected and docosahexaenoic acid (DHA) was significantly lower. Histopathologic analyses documented that mice on the ω-6 diet had a significant increase in macrovesicular steatosis, extramedullary myelopoiesis (EMM), apoptotic hepatocytes and decreased glycogen storage in lobular hepatocytes, and hepatocyte proliferation relative to mice fed the Lc ω-3 diet. Together, these results support PUFA dietary regulation of hepatic pathology and inflammation with implications for enteral feeding regulation of steatosis and other hepatic lesions.

KW - Diet

KW - Fatty liver

KW - Fish oil

KW - Hepatic steatosis

KW - Omega-3

KW - PUFA

UR - http://www.scopus.com/inward/record.url?scp=85034668585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034668585&partnerID=8YFLogxK

U2 - 10.1016/j.jnutbio.2017.09.017

DO - 10.1016/j.jnutbio.2017.09.017

M3 - Article

C2 - 29175671

AN - SCOPUS:85034668585

VL - 52

SP - 92

EP - 102

JO - Journal of Nutritional Biochemistry

JF - Journal of Nutritional Biochemistry

SN - 0955-2863

ER -